drugset / Trial / NCT00529282

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

NCT00529282

Phase 3 Terminated 2 enrolled Basilea Pharmaceutica
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of ceftobiprole versus a comparator in patients with fever and neutropenia

Timeline

Start
2007-10
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefepime Small molecule 2 g
Subject Ceftobiprole Small molecule 500 mg
Comparator Vancomycin Other / unclassified 1000 mg